NEJM’s retraction of the key avacopan paper reflects concerns about data used for approval of this autoimmune disease drug, which has been linked to liver injury.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/amgen-fights-keep-avacopan-market-amid-growing-concerns-2026a1000mm9?src=rss
Author :
Publish date : 2026-07-03 08:37:00
Copyright for syndicated content belongs to the linked Source.